Can a new scanner match the gold standard in nuclear imaging?
NCT ID NCT07725237
First seen Jul 24, 2026 · Last updated Jul 24, 2026
Summary
This trial compares a new SPECT/CT scanner, StarGuide GX, to a currently used reference scanner in adults who already need a SPECT/CT scan as part of their care. Each participant will receive two scans using the same tracer dose, one on each scanner, to see if the StarGuide GX produces comparable images. The goal is to collect image data and participant feedback to evaluate the new system's performance in a real clinical setting.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- StarGuide GX SPECT/CT Scan
- What this could lead to
- If successful, this could help confirm that the StarGuide GX scanner is a reliable alternative for routine SPECT/CT imaging.
- What could go wrong
- This is a small, early-stage device demonstration with only 30 participants, focused on data collection rather than clinical outcomes. It may not prove superiority or broad applicability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPECT-CT are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Rambam Health Care Campus
Haifa, 3109601, Israel
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.